Federal and State Policymakers Push Forward with PBM and Drug Pricing Reform Even in the Wake of Sweeping Actions Earlie...
Despite the flurry of reform activity throughout the first quarter of 2026, the pace of new PBM regulation and drug pricing reforms shows no sign of tapering off. Instead, both fed...